Coronavirus: Vaccination
The question
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the cost effectiveness of the covid-19 vaccine booster programme, in the context of the findings on the impact of vaccination take-up in care homes on resident mortality in the report by Sourafel Girma and David Paton entitled Using double-debiased machine learning to estimate the impact of Covid-19 vaccination on mortality and staff absences in elderly care homes, published in European Economic Review, Volume 170, November 2024.
Answered by Andrew Gwynne
The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The JCVI considers the cost effectiveness of immunisation strategies, alongside a range of data, including epidemiological and vaccine effectiveness data, when formulating its advice. On 13 November 2024, the JCVI published advice on the COVID-19 vaccination programme in 2025 and spring 2026. This advice is available at the following link:
https://www.gov.uk/government/publications/covid-19-vaccination-in-2025-and-spring-2026
The Government is considering this advice carefully and will respond in due course.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →